127 related articles for article (PubMed ID: 16306446)
1. Cardiomyocyte cell cycle activation ameliorates fibrosis in the atrium.
Nakajima H; Nakajima HO; Dembowsky K; Pasumarthi KB; Field LJ
Circ Res; 2006 Jan; 98(1):141-8. PubMed ID: 16306446
[TBL] [Abstract][Full Text] [Related]
2. Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart.
Nakajima H; Nakajima HO; Salcher O; Dittiè AS; Dembowsky K; Jing S; Field LJ
Circ Res; 2000 Mar; 86(5):571-9. PubMed ID: 10720419
[TBL] [Abstract][Full Text] [Related]
3. Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1.
Verheule S; Sato T; Everett T; Engle SK; Otten D; Rubart-von der Lohe M; Nakajima HO; Nakajima H; Field LJ; Olgin JE
Circ Res; 2004 Jun; 94(11):1458-65. PubMed ID: 15117823
[TBL] [Abstract][Full Text] [Related]
4. Expression of mutant p193 and p53 permits cardiomyocyte cell cycle reentry after myocardial infarction in transgenic mice.
Nakajima H; Nakajima HO; Tsai SC; Field LJ
Circ Res; 2004 Jun; 94(12):1606-14. PubMed ID: 15142950
[TBL] [Abstract][Full Text] [Related]
5. Targeted expression of cyclin D2 ameliorates late stage anthracycline cardiotoxicity.
Zhu W; Reuter S; Field LJ
Cardiovasc Res; 2019 Apr; 115(5):960-965. PubMed ID: 30423020
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.
Rahmutula D; Marcus GM; Wilson EE; Ding CH; Xiao Y; Paquet AC; Barbeau R; Barczak AJ; Erle DJ; Olgin JE
Cardiovasc Res; 2013 Sep; 99(4):769-79. PubMed ID: 23612580
[TBL] [Abstract][Full Text] [Related]
7. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.
Gruver CL; DeMayo F; Goldstein MA; Means AR
Endocrinology; 1993 Jul; 133(1):376-88. PubMed ID: 8319584
[TBL] [Abstract][Full Text] [Related]
8. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes.
Huh NE; Pasumarthi KB; Soonpaa MH; Jing S; Patton B; Field LJ
J Mol Cell Cardiol; 2001 Aug; 33(8):1405-19. PubMed ID: 11448130
[TBL] [Abstract][Full Text] [Related]
9. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.
Hanna N; Cardin S; Leung TK; Nattel S
Cardiovasc Res; 2004 Aug; 63(2):236-44. PubMed ID: 15249181
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial apoptotic pathway activation in the atria of heart failure patients due to mitral and tricuspid regurgitation.
Chang JP; Chen MC; Liu WH; Lin YS; Huang YK; Pan KL; Ho WC; Fang CY; Chen CJ; Chen HC
Exp Mol Pathol; 2015 Aug; 99(1):65-73. PubMed ID: 26004742
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
12. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.
On YK; Jeon ES; Lee SY; Shin DH; Choi JO; Sung J; Kim JS; Sung K; Park P
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1515-20. PubMed ID: 19464473
[TBL] [Abstract][Full Text] [Related]
13. MLC3F transgene expression in iv mutant mice reveals the importance of left-right signalling pathways for the acquisition of left and right atrial but not ventricular compartment identity.
Franco D; Kelly R; Moorman AF; Lamers WH; Buckingham M; Brown NA
Dev Dyn; 2001 Jun; 221(2):206-15. PubMed ID: 11376488
[TBL] [Abstract][Full Text] [Related]
14. The cardiomyocyte cell cycle.
Lafontant PJ; Field LJ
Novartis Found Symp; 2006; 274():196-207; discussion 208-13, 272-6. PubMed ID: 17019813
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
[TBL] [Abstract][Full Text] [Related]
16. A prospective DE-MRI study evaluating the role of TGF-β1 in left atrial fibrosis and implications for outcomes of cryoballoon-based catheter ablation: new insights into primary fibrotic atriocardiomyopathy.
Canpolat U; Oto A; Hazirolan T; Sunman H; Yorgun H; Şahiner L; Kaya EB; Aytemir K
J Cardiovasc Electrophysiol; 2015 Mar; 26(3):251-9. PubMed ID: 25366936
[TBL] [Abstract][Full Text] [Related]
17. Defining "culprit mechanisms" in arrhythmogenic cardiac remodeling.
Nattel S
Circ Res; 2004 Jun; 94(11):1403-5. PubMed ID: 15192034
[No Abstract] [Full Text] [Related]
18. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
19. Recombinant neuregulin 1 does not activate cardiomyocyte DNA synthesis in normal or infarcted adult mice.
Reuter S; Soonpaa MH; Firulli AB; Chang AN; Field LJ
PLoS One; 2014; 9(12):e115871. PubMed ID: 25545368
[TBL] [Abstract][Full Text] [Related]
20. Calreticulin overexpression correlates with integrin-α5 and transforming growth factor-β1 expression in the atria of patients with rheumatic valvular disease and atrial fibrillation.
Zhao F; Zhang S; Shao Y; Wu Y; Qin J; Chen Y; Chen L; Gu H; Wang X; Huang C; Zhang W
Int J Cardiol; 2013 Oct; 168(3):2177-85. PubMed ID: 23465222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
